First Trust Advisors
NUVB icon

First Trust Advisors’s Nuvation Bio NUVB Stock Holding History

First Trust Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.4M Buy
+1,302,337
New +$6.37M ﹤0.01% 1358

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

First Trust Advisors's NUVB Position: Q2 2026 in Review

First Trust Advisors opened a new position in Nuvation Bio (NUVB) in Q2 2026: 1,302,337 shares worth $7.4M. The stake represents ﹤0.01% of the portfolio and ranks #1358 among its holdings.

109 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • First Trust Advisors held 1,302,337 shares of Nuvation Bio worth $7.4M as of Q2 2026.
  • Nuvation Bio was a new First Trust Advisors position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1358 holding.
  • 109 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.